Triamterene
Back to searchMolecule Structure
Scientific Name
Triamterene
Description of the Drug
Triamterene is a potassium-sparing diuretic used in the treatment of edema and in the management of hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00384
http://www.drugbank.ca/drugs/DB00384
Brand Name(s)
Dyrenium, Dytac
Company Owner(s)
Eywa Pharma Inc, Vitarine Pharmaceuticals Inc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Glaxosmithkline Llc, Novartis Pharmaceuticals Corp, Zydus Pharmaceuticals Usa Inc, Rubicon Research Private Ltd, Ani Pharmaceuticals Inc, Sandoz Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Amiloride-sensitive sodium channel, ENaC | PROTEIN COMPLEX | BLOCKER | CHEMBL2107836 |
Clinical Trial(s)
Unichem Links
| Atlas | triamterene | |
| SureChEMBL | SCHEMBL40707 | |
| PharmGKB | PA451752 | |
| Human Metabolome Database | HMDB0001940 | |
| DrugBank | DB00384 | |
| PubChem: Thomson Pharma | 14774401 | |
| PubChem | 5546 | |
| Mcule | MCULE-5832721534 | |
| LINCS | LSM-4060 | |
| Nikkaji | J2.040K | |
| PDBe | DX2 | |
| BindingDB | 6644 | |
| EPA CompTox Dashboard | DTXSID6021373 | |
| DrugCentral | 2728 | |
| Brenda | 45956 | 27748 |
| ChemicalBook | CB0663775 | |
| Guide to Pharmacology | 4329 | |
| rxnorm | DYRENIUM | TRIAMTERENE |
| ChEBI | 9671 | |
| ZINC | ZINC000000120286 |
